Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Real-life challenges using personalized prognostic scoring systems in acute myeloid leukemia.

Cancer medicine - 1 Mar 2023

Calleja Anne, Loschi Michael, Bailly Laurent, Morisot Adeline, Marceau Alice, Mannone Lionel, Robert Guillaume, Auberger Patrick, Preudhomme Claude, Raynaud Sophie, Subtil Fabien, Sujobert Pierre, Cluzeau Thomas

Abstract excerpt

Personalized medicine is a challenge for patients with acute myeloid leukemia (AML). The identification of several genetic mutations in several AML trials led to the creation of a personalized prognostic scoring algorithm known as the Knowledge Bank (KB). In this study, we assessed the prognostic value of this algorithm on a cohort of 167 real life AML patients. We compared KB predicted outcomes to real-life...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hematopoietic Stem Cell Transplantation
Share to Leukemia, Myeloid, Acute

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Prognosis

Source

Open in PubMed Open full text

Identifiers

PMID: 36394159
DOI: 10.1002/cam4.5408
PMCID: PMC10028034

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Real-life challenges using personalized prognostic scoring systems in acute myeloid leukemia.PMID 36394159Read ↗

AML Risk Stratification Models Utilizing ELN-2017 Guidelines and Additional Prognostic Factors: A SWOG ReportSemantic proximity Read ↗

A scoring system for AML patients aged 70 years or older, eligible for intensive chemotherapy: a study based on a large European data set using the DATAML, SAL, and PETHEMA registries.Semantic proximity Read ↗

Personalized Survival Prediction of Patients With Acute Myeloblastic Leukemia Using Gene Expression ProfilingSemantic proximity Read ↗

Novel Prognostic and Therapeutic Mutations in Acute Myeloid Leukemia.Semantic proximity Read ↗

Outcome prediction by the 2022 European LeukemiaNet genetic-risk classification for adults with acute myeloid leukemia: an Alliance study.Semantic proximity Read ↗

Personally tailored cancer management based on knowledge banks of genomic and clinical dataSemantic proximity Read ↗

Validation of risk stratification models in acute myeloid leukemia using sequencing-based molecular profilingSemantic proximity Read ↗

A precision medicine classification for treatment of acute myeloid leukemia in older patients.Semantic proximity Read ↗

Integrating genomics into prognostic models for AML.Semantic proximity Read ↗

Comparison and validation of the 2022 European LeukemiaNet guidelines in acute myeloid leukemia.Semantic proximity Read ↗

Development and validation of a prognostic scoring model to risk stratify childhood acute myeloid leukaemia.Semantic proximity Read ↗

Development and validation of a prognostic model for adult patients with acute myeloid leukaemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.